Studies kidney injury in newborns admitted to intensive care worldwide
Looks back at kidney injury in newborns cared for in intensive care units.
Key facts
- Who runs it
- Indiana University
- Where
- Akron, Ann Arbor, Atlanta, Augusta, Aurora, Baltimore, Birmingham, Boston, Brooklyn, Burlington, Chapel Hill, Charleston, Charlottesville, Chicago, Cincinnati, Columbus, Dallas, Hartford, Houston, Indianapolis, Iowa City, Kansas City, Lexington, Little Rock, Louisville, Lubbock, Madison, Miami, Milwaukee, Minneapolis, Nashville, New Haven, Omaha, Palo Alto, Philadelphia, Pittsburgh, Portland, Queens, Rochester, Salt Lake City, San Antonio, San Diego, Seattle, South Miami, Springfield, St Louis, Stony Brook, The Bronx, Washington D.C., Westchester, and Winston-Salem, United StatesSee the 53 sitesAlso in 32 other countries, 72 sites
- Trial code
- Registry title
- Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
- Status
- Enrolling by invitation
- People taking part
- 8,000 people, planned
- Started
- 1 Mar 2025
- Expected to end
- Jun 2027
- Type of study
- Observational
- Record updated
- 28 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial looks back at records of newborn babies treated in a level 3 or 4 neonatal intensive care unit. It is looking for babies who received fluids through a vein for more than 48 hours.
- Age
- Babies up to 2 weeks old.
- Sex
- All sexes can join.
- Earlier treatment
- The baby must have received intravenous fluids for more than 48 hours.
Main reasons for not taking part
- Age over 14 days at admission
- Congenital heart disease needing transfer for heart care or surgery within the first 7 days
- Lethal chromosomal anomalies
- Death of the newborn within 48 hours
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- All infants born or admitted to a participating level 3 or 4 NICU between 1/1/19- 3/31/19 will be screened
- Infants who received intravenous fluids for > 48 hours will be eligible
Who cannot take part
- Congenital heart disease requiring transfer for escalation of CHD care and/or surgery within the first 7 days
- Age > 14 days at admission
- Lethal chromosomal anomalies
- Neonatal mortality <48 hours
Where in United States
Also in 32 other countries, 72 sites
- Akron Children's HospitalAkron, United StatesEnrolling by invitation
- University of MichiganAnn Arbor, United StatesEnrolling by invitation
- Emory Healthcare / Children's Healthcare of AtlantaAtlanta, United StatesEnrolling by invitation
- Children's Hospital of GeorgiaAugusta, United StatesEnrolling by invitation
- Children's Hospital ColoradoAurora, United StatesEnrolling by invitation
- Johns Hopkins University HospitalBaltimore, United StatesEnrolling by invitation
- University of MarylandBaltimore, United StatesEnrolling by invitation
- University of Alabama at BirminghamBirmingham, United StatesEnrolling by invitation
- Boston Children's HospitalBoston, United StatesEnrolling by invitation
- Maimonides Medical CenterBrooklyn, United StatesEnrolling by invitation
- Golisano Children's Hospital at University of Vermont HealthBurlington, United StatesEnrolling by invitation
- UNCChapel Hill, United StatesEnrolling by invitation
- Medical University of South CarolinaCharleston, United StatesEnrolling by invitation
- University of VirginiaCharlottesville, United StatesEnrolling by invitation
- Lurie Children's Hospital of ChicagoChicago, United StatesEnrolling by invitation
- Cincinnati Children's HospitalCincinnati, United StatesEnrolling by invitation
- Nationwide Children'sColumbus, United StatesEnrolling by invitation
- UT SouthwesternDallas, United StatesEnrolling by invitation
- Connecticut Children's Medical CenterHartford, United StatesEnrolling by invitation
- Texas Children's HospitalHouston, United StatesEnrolling by invitation
- Indiana University School of MedicineIndianapolis, United StatesEnrolling by invitation
- Riley Hospital for ChildrenIndianapolis, United StatesEnrolling by invitation
- University of IowaIowa City, United StatesEnrolling by invitation
- Children's Mercy HospitalKansas City, United StatesEnrolling by invitation
- University of KentuckyLexington, United StatesEnrolling by invitation
- University of Arkansas for Medical SciencesLittle Rock, United StatesEnrolling by invitation
- University of LouisvilleLouisville, United StatesEnrolling by invitation
- Texas TechLubbock, United StatesEnrolling by invitation
- University of WisconsinMadison, United StatesEnrolling by invitation
- Miami Children's / Nichlaus Children's HospitalMiami, United StatesEnrolling by invitation
- Medical College of Wisconsin, Children's WisconsinMilwaukee, United StatesEnrolling by invitation
- University of MinnesotaMinneapolis, United StatesEnrolling by invitation
- Monroe Carell Jr. Children's Hospital at VanderbiltNashville, United StatesEnrolling by invitation
- Yale UniversityNew Haven, United StatesEnrolling by invitation
- Children's NebraskaOmaha, United StatesEnrolling by invitation
- Stanford Children'sPalo Alto, United StatesEnrolling by invitation
- Children's Hospital of PhiladelphiaPhiladelphia, United StatesEnrolling by invitation
- University of Pittsburgh Medical CenterPittsburgh, United StatesEnrolling by invitation
- OHSUPortland, United StatesEnrolling by invitation
- Cohen Children's HospitalQueens, United StatesEnrolling by invitation
- University of Rochester / Golisano Children's HospitalRochester, United StatesEnrolling by invitation
- Primary Children's HospitalSalt Lake City, United StatesEnrolling by invitation
- Christus Children's HospitalSan Antonio, United StatesEnrolling by invitation
- Rady Children's Hospital/UCSDSan Diego, United StatesEnrolling by invitation
- Seattle Children's Hospital; University of WashingtonSeattle, United StatesEnrolling by invitation
- Baptist Health South Florida/South Miami HospitalSouth Miami, United StatesEnrolling by invitation
- SIUSpringfield, United StatesEnrolling by invitation
- Washington UniversitySt Louis, United StatesEnrolling by invitation
- Stony Brook MedicineStony Brook, United StatesEnrolling by invitation
- Children's Hospital at MontefioreThe Bronx, United StatesEnrolling by invitation
- Children's National HospitalWashington D.C., United StatesEnrolling by invitation
- Westchester Medical Center/Maria Fareri Children's HospitalWestchester, United StatesEnrolling by invitation
- Wake ForestWinston-Salem, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
There is a growing focus on short- and long-term kidney health in neonates, including those with acute kidney injury (AKI). AKI occurs commonly in the Neonatal Intensive Care Unit (NICU) and is associated with adverse outcomes. In addition to poor outcomes during the hospitalization, infants discharged from the NICU may have an increased burden of kidney disease during childhood. Studies of long-term kidney function in children born prematurely show a fourfold increase in chronic kidney disease (CKD) by adolescence and into adulthood.
Read full original descriptionShow less
Despite the landmark findings of the Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates (AWAKEN) study, the limitations of this study are notable. First, the AWAKEN study enrolled infants admitted in 2014, making the data now over 10 years old. Much has changed in neonatal practice (e.g. increased AKI awareness, treatment strategies). Secondly, the findings of the AWAKEN study were geographically limited. While the AWAKEN study was multi-national and multi-center, it represented only 24 centers (22 from North America, 1 from India and 1 from Australia). Finally, information collected from AWAKEN ended at hospital discharge.
The investigators seek to leverage the strength of the Neonatal Kidney Collaborative along with other organizations and collaboratives interested in neonatal kidney health to address these gaps. Therefore, the investigators are conducting a second, modified iteration of this study entitled "AWAKEN 2.0". AWAKEN 2.0 will be a multi-center multi-national retrospective analysis utilizing similar methodology to the AWAKEN study.
The group in the trial
- Neonates at Risk of Kidney Disease
Inclusion Criteria 1. Admitted to participating NICUs between 1/1/19- 3/31/19 2. \> 48 hours of IV fluids Exclusion Criteria 1. Age \> 14 days at admission 2. Congenital heart disease requiring transfer for escalation of CHD care and/or surgery within the first 7 days 3. Lethal chromosomal anomalies 4. Neonatal mortality \<48 hours
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0: Towards Expanding Our Understanding of Neonatal Acute Kidney Injury
- Plain-language title
- Studies kidney injury in newborns admitted to intensive care worldwideGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 28 October 2026